{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:17:52Z","timestamp":1791091072135,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,4,22]],"date-time":"2010-04-22T00:00:00Z","timestamp":1271894400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Infect Dis Rep"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1007\/s11908-010-0098-z","type":"journal-article","created":{"date-parts":[[2010,4,21]],"date-time":"2010-04-21T13:49:30Z","timestamp":1271857770000},"page":"174-180","source":"Crossref","is-referenced-by-count":16,"title":["New Vaccines for Japanese Encephalitis"],"prefix":"10.1007","volume":"12","author":[{"given":"Scott B.","family":"Halstead","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,4,22]]},"reference":[{"key":"98_CR1","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1056\/NEJMra030476","volume":"351","author":"T Solomon","year":"2004","unstructured":"Solomon T: Flavivirus encephalitis. N Engl J Med 2004, 351:370\u2013378.","journal-title":"N Engl J Med"},{"key":"98_CR2","doi-asserted-by":"crossref","unstructured":"Halstead S, Jacobson J: Japanese encephalitis vaccines. In Vaccines, edn 5. Edited by Plotkin SA, Orenstein WA, Offit PA. Philadelphia: Elsevier; 2008:311\u2013352.","DOI":"10.1016\/B978-1-4160-3611-1.50021-0"},{"key":"98_CR3","first-page":"190","volume":"75","author":"SB Halstead","year":"1962","unstructured":"Halstead SB, Grosz CR: Subclinical Japanese encephalitis. I. Infection of Americans with limited residence in Korea. Am J Hyg 1962, 75:190\u2013201.","journal-title":"Am J Hyg"},{"issue":"6 Pt 1","key":"98_CR4","doi-asserted-by":"crossref","first-page":"974","DOI":"10.4269\/ajtmh.1975.24.974","volume":"24","author":"MW Benenson","year":"1975","unstructured":"Benenson MW, Top FH Jr, Gresso W, et al.: The virulence to man of Japanese encephalitis virus in Thailand. Am J Trop Med Hyg 1975, 24(6 Pt 1):974\u2013980.","journal-title":"Am J Trop Med Hyg"},{"key":"98_CR5","first-page":"237","volume":"73","author":"A Gajanana","year":"1995","unstructured":"Gajanana A, Thenmozhi V, Samuel PP, Reuben R: A community-based study of subclinical flavivirus infections in children in an area of Tamil Nadu, India, where Japanese encephalitis is endemic. Bull WHO 1995, 73: 237\u2013244.","journal-title":"Bull WHO"},{"key":"98_CR6","first-page":"171","volume":"267","author":"T Solomon","year":"2002","unstructured":"Solomon T, Vaughn DW: Pathogenesis and clinical features of Japanese encephalitis and West Nile virus infections. Curr Top Micro Immunol 2002, 267:171\u2013194.","journal-title":"Curr Top Micro Immunol"},{"key":"98_CR7","doi-asserted-by":"crossref","unstructured":"\u2022 Vaughn DW, Barrett A, Solomon T: Flaviviruses (yellow fever, dengue, dengue hemorrhagic fever, Japanese encephalitis, St. Louis encephalitis, tick-borne encephalitis). In Principals and Practice of Infectious Diseases, edn 7. Edited by Mandell GL, Bennett JE, Dolin R. Philadelphia: Churchill Livingstone; 2009:2133\u20132156. This chapter provides a comprehensive clinical overview of diseases caused by flaviviruses.","DOI":"10.1016\/B978-0-443-06839-3.00153-3"},{"issue":"Pt 5","key":"98_CR8","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1093\/brain\/awf116","volume":"125","author":"T Solomon","year":"2002","unstructured":"Solomon T, Dung NM, Kneen R, et al.: Seizures and raised intracranial pressure in Vietnamese patients with Japanese encephalitis. Brain 2002, 125(Pt 5):1084\u20131093.","journal-title":"Brain"},{"key":"98_CR9","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0002-9343(52)90356-2","volume":"12","author":"RB Dickerson","year":"1952","unstructured":"Dickerson RB, Newton JR, Hansen JE: Diagnosis and immediate prognosis of Japanese B encephalitis; observations based on more than 200 patients with detailed analysis of 65 serologically confirmed cases. Am J Med 1952, 12: 277\u201388.","journal-title":"Am J Med"},{"key":"98_CR10","first-page":"465","volume":"18","author":"K Kimura","year":"1997","unstructured":"Kimura K, Dosaka A, Hashimoto Y, et al.: Single-photon emission CT findings in acute Japanese encephalitis. AJNR Am J Neuroradiol 1997, 18: 465\u2013469.","journal-title":"AJNR Am J Neuroradiol"},{"key":"98_CR11","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1136\/jnnp.57.12.1484","volume":"57","author":"UK Misra","year":"1994","unstructured":"Misra UK, Kalita J, Jain SK, et al.: Radiological and neurophysiological changes in Japanese encephalitis. J Neurol Neurosurg Psych 1994, 57: 1484\u20131487.","journal-title":"J Neurol Neurosurg Psych"},{"key":"98_CR12","first-page":"9","volume":"97","author":"R Kumar","year":"1993","unstructured":"Kumar R, Mathur A, Singh KB, et al.: Clinical sequelae of Japanese encephalitis in children. Ind J Med Res 1993, 97:9\u201313.","journal-title":"Ind J Med Res"},{"key":"98_CR13","first-page":"332","volume":"16","author":"C Harinasuta","year":"1985","unstructured":"Harinasuta C, Nimmanitya S, Titsyakorn U: The effect of interferon-alpha A on two cases of Japanese encephalitis in Thailand. Southeast Asian J Trop Med Public Health 1985, 16: 332\u2013336.","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"98_CR14","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1086\/596309","volume":"48","author":"R Kumar","year":"2009","unstructured":"Kumar R, Tripathi P, Baranwal M, et al.: Randomized, controlled trial of oral ribavirin for Japanese encephalitis in children in Uttar Pradesh, India. Clin Infect Dis 2009, 48:400\u2013406.","journal-title":"Clin Infect Dis"},{"key":"98_CR15","doi-asserted-by":"crossref","first-page":"441","DOI":"10.4269\/ajtmh.1958.7.441","volume":"7","author":"WM Hammon","year":"1958","unstructured":"Hammon WM, Tigertt WD, Sather GE, et al.: Epidemiologic studies of concurrent virgin epidemics of Japanese B encephalitis and of mumps on Guam, 1947\u20131948, with subsequent observations including dengue, through 1957. Am J Trop Med Hyg 1958, 7:441\u2013467.","journal-title":"Am J Trop Med Hyg"},{"key":"98_CR16","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0035-9203(02)90294-4","volume":"96","author":"DH Libraty","year":"2002","unstructured":"Libraty DH, Nisalak A, Endy TP, et al.: Clinical and immunological risk factors for severe disease in Japanese encephalitis. Trans R Soc Trop Med Hyg 2002, 96:173\u2013178.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"98_CR17","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/0035-9203(94)90200-3","volume":"88","author":"D Luo","year":"1994","unstructured":"Luo D, Yao R, Song J, et al.: The effect of DDT spraying and bed nets impregnated with pyrethroid insecticide on the incidence of Japanese encephalitis virus infection. Trans R Soc Trop Med Hyg 1994, 88:629\u2013631.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"98_CR18","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/0035-9203(94)90201-1","volume":"88","author":"D Luo","year":"1994","unstructured":"Luo D, Zhang K, Song J, et al.: The protective effect of bed nets impregnated with pyrethroid insecticide and vaccination against Japanese encephalitis. Trans R Soc Trop Med Hyg 1994, 88:632\u2013634.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"Suppl 2","key":"98_CR19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0264-410X(00)00038-4","volume":"18","author":"L Markoff","year":"2000","unstructured":"Markoff L: Points to consider in the development of a surrogate for efficacy of novel Japanese encephalitis virus vaccines. Vaccine 2000, 18(Suppl 2):26\u201332.","journal-title":"Vaccine"},{"key":"98_CR20","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.1016\/j.vaccine.2005.07.002","volume":"23","author":"J Hombach","year":"2005","unstructured":"Hombach J, Solomon T, Kurane I, et al.: Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2\u20133 September, 2004. Vaccine 2005, 23:5205\u20135211.","journal-title":"Vaccine"},{"key":"98_CR21","doi-asserted-by":"crossref","unstructured":"Paulke-Korinek M, Kollaritsch H: Japanese encephalitis and vaccines: past and future prospects. Wien Klin Wochenschr 2008, 120(19\u201320 Suppl 4):15\u201319.","DOI":"10.1007\/s00508-008-1071-9"},{"key":"98_CR22","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Schioler KL, Samuel M, Wai KL: Vaccines for preventing Japanese encephalitis. Cochrane Database Syst Rev 2007. Available at http:\/\/www.cochrane.org\/reviews\/en\/ab004263.html . Accessed February 2010. The authors performed an authoritative search of the literature through March 2007 for trials assessing Japanese encephalitis vaccine in terms of effectiveness, adverse events, and immunogenicity.","DOI":"10.1002\/14651858.CD004263.pub2"},{"key":"98_CR23","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1586\/14760584.7.5.689","volume":"7","author":"T Jelinek","year":"2008","unstructured":"Jelinek T: Japanese encephalitis vaccine in travelers. Expert Rev Vaccines 2008, 7:689\u2013693.","journal-title":"Expert Rev Vaccines"},{"key":"98_CR24","unstructured":"Inactivated Japanese encephalitis virus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1993, 42(RR-1):1\u201315."},{"key":"98_CR25","first-page":"242","volume":"80","author":"Global Advisory Committee on Vaccine Safety","year":"2005","unstructured":"Global Advisory Committee on Vaccine Safety, 9\u201310 June 2005. Wkly Epidemiol Rec 2005, 80:242\u2013247.","journal-title":"Wkly Epidemiol Rec"},{"key":"98_CR26","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1056\/NEJM198809083191004","volume":"319","author":"CH Hoke","year":"1988","unstructured":"Hoke CH, Nisalak A, Sangawhipa N, et al.: Protection against Japanese encephalitis by inactivated vaccines. N Engl J Med 1988, 319:608\u2013614.","journal-title":"N Engl J Med"},{"key":"98_CR27","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1517\/14712598.8.1.95","volume":"8","author":"DW Beasley","year":"2008","unstructured":"Beasley DW, Lewthwaite P, Solomon T: Current use and development of vaccines for Japanese encephalitis. Expert Opin Biol Ther 2008, 8:95\u2013106.","journal-title":"Expert Opin Biol Ther"},{"key":"98_CR28","first-page":"337","volume":"1991","author":"MM Andersen","year":"1044","unstructured":"Andersen MM, Ronne T: Side-effects with Japanese encephalitis vaccine. Lancet 1991, 337:1044.","journal-title":"Lancet"},{"key":"98_CR29","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/0140-6736(91)91531-X","volume":"338","author":"TA Ruff","year":"1991","unstructured":"Ruff TA, Eisen D, Fuller A, et al.: Adverse reactions to Japanese encephalitis vaccine. Lancet 1991, 338:881\u2013882.","journal-title":"Lancet"},{"key":"98_CR30","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0140-6736(01)05967-0","volume":"358","author":"MB Bista","year":"2001","unstructured":"Bista MB, Banerjee MK, Shin SH, et al.: Efficacy of single-dose SA 14-14-2 vaccine against Japanese encephalitis: a case control study. Lancet 2001, 358:791\u2013795.","journal-title":"Lancet"},{"key":"98_CR31","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0140-6736(05)67567-8","volume":"366","author":"H Ohrr","year":"2005","unstructured":"Ohrr H, Tandan JB, Sohn YM, et al.: Effect of single dose of SA 14-14-2 vaccine 1 year after immunisation in Nepalese children with Japanese encephalitis: a case-control study. Lancet 2005, 366:1375\u20131378.","journal-title":"Lancet"},{"key":"98_CR32","doi-asserted-by":"crossref","first-page":"5041","DOI":"10.1016\/j.vaccine.2007.04.052","volume":"25","author":"JB Tandan","year":"2007","unstructured":"Tandan JB, Ohrr H, Sohn YM, et al.: Single dose of SA 14-14-2 vaccine provides long-term protection against Japanese encephalitis: a case-control study in Nepalese children 5 years after immunization. Vaccine 2007, 25:5041\u20135045.","journal-title":"Vaccine"},{"key":"98_CR33","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1056\/NEJMc0808664","volume":"360","author":"R Kumar","year":"2009","unstructured":"Kumar R, Tripathi P, Rizvi A: Effectiveness of one dose of SA 14-14-2 vaccine against Japanese encephalitis. N Engl J Med 2009, 360:1465\u20131466.","journal-title":"N Engl J Med"},{"key":"98_CR34","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1016\/j.vaccine.2008.02.042","volume":"26","author":"S Gatchalian","year":"2008","unstructured":"Gatchalian S, Yao Y, Zhou B, et al.: Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants. Vaccine 2008, 26:2234\u20132241.","journal-title":"Vaccine"},{"key":"98_CR35","doi-asserted-by":"crossref","unstructured":"Solomon T: Control of Japanese encephalitis\u2014within our grasp? N Engl J Med 2006, 355:9:869\u2013871.","DOI":"10.1056\/NEJMp058263"},{"key":"98_CR36","doi-asserted-by":"crossref","unstructured":"\u2022 Kollaritsch H, Paulke-Korinek M, Dubischar-Kastner K: IC51 Japanese encephalitis vaccine. Expert Opin Biol Ther 2009, 9:7:921\u2013931. This article provides an excellent overview of IC51 development history and pathway.","DOI":"10.1517\/14712590903042282"},{"key":"98_CR37","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0264-410X(88)90103-X","volume":"6","author":"KH Eckels","year":"1988","unstructured":"Eckels KH, Yu YX, Dubois DR, et al.: Japanese encephalitis virus live-attenuated vaccine, Chinese strain SA14-14-2; adaptation to primary canine kidney cell cultures and preparation of a vaccine for human use. Vaccine 1988, 6: 513\u2013518.","journal-title":"Vaccine"},{"key":"98_CR38","first-page":"27","volume":"70","author":"BJ Montagnon","year":"1989","unstructured":"Montagnon BJ. Polio and rabies vaccines produced in continuous cell lines: a reality for Vero cell line. Devel Biol Stand 1989, 70:27\u201347.","journal-title":"Devel Biol Stand"},{"key":"98_CR39","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1016\/S0264-410X(01)00208-0","volume":"19","author":"AK Srivastava","year":"2001","unstructured":"Srivastava AK, Putnak JR, Lee SH, et al. A purified inactivated Japanese encephalitis virus vaccine made in Vero cells. Vaccine 2001, 19:4557\u20134565.","journal-title":"Vaccine"},{"key":"98_CR40","doi-asserted-by":"crossref","unstructured":"Lyons A, Kanesa-thasan N, Kuschner RA, et al.: A Phase 2 study of a purified, inactivated virus vaccine to prevent Japanese encephalitis. Vaccine 2007, 25:17:3445\u20133453.","DOI":"10.1016\/j.vaccine.2006.12.046"},{"key":"98_CR41","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/S0140-6736(07)61780-2","volume":"370","author":"E Tauber","year":"2007","unstructured":"Tauber E, Kollaritsch H, Korinek M, et al.: Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial. Lancet 2007, 370:1847\u20131853.","journal-title":"Lancet"},{"key":"98_CR42","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1086\/590116","volume":"198","author":"E Tauber","year":"2008","unstructured":"Tauber E, Kollaritsch H, von Sonnenburg F, et al.: Randomized, double-blind, placebo-controlled phase 3 trial of the safety and tolerability of IC51, an inactivated Japanese encephalitis vaccine. J Infect Dis 2008, 198:493\u2013499.","journal-title":"J Infect Dis"},{"key":"98_CR43","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1016\/j.vaccine.2008.05.081","volume":"26","author":"E Schuller","year":"2008","unstructured":"Schuller E, Jilma B, Voicu V, et al.: Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51 Six and 12\u00a0month results of a multicenter follow-up phase 3 study. Vaccine 2008, 26:4382\u20134386.","journal-title":"Vaccine"},{"key":"98_CR44","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.vaccine.2008.12.062","volume":"27","author":"E Schuller","year":"2009","unstructured":"Schuller E, Klade CS, Wolfl G, et al.: Comparison of a single, high-dose vaccination regimen to the standard regimen for the investigational Japanese encephalitis vaccine, IC51: a randomized, observer-blind, controlled Phase 3 study. Vaccine 2009, 27:2188\u20132193.","journal-title":"Vaccine"},{"key":"98_CR45","doi-asserted-by":"crossref","first-page":"6151","DOI":"10.1016\/j.vaccine.2008.08.056","volume":"26","author":"E Schuller","year":"2008","unstructured":"Schuller E, Klade CS, Heinz FX, et al.: Effect of pre-existing anti-tick-borne encephalitis virus immunity on neutralising antibody response to the Vero cell-derived, inactivated Japanese encephalitis virus vaccine candidate IC51. Vaccine 2008, 26:6151\u20136156.","journal-title":"Vaccine"},{"key":"98_CR46","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1016\/j.vaccine.2009.05.034","volume":"27","author":"A Kaltenbock","year":"2009","unstructured":"Kaltenbock A, Dubischar-Kastner K, Eder G, et al.: Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese Encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX1440 in healthy subjects: A single-blind, randomized, controlled Phase 3 study. Vaccine 2009, 27:4483\u20134489.","journal-title":"Vaccine"},{"key":"98_CR47","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1128\/JVI.73.4.3095-3101.1999","volume":"73","author":"TJ Chambers","year":"1999","unstructured":"Chambers TJ, Nestorowicz A, Mason PW, Rice CM: Yellow fever\/Japanese encephalitis chimeric viruses: construction and biological properties. J Virol 1999, 73:3095\u20133101.","journal-title":"J Virol"},{"key":"98_CR48","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/S0264-410X(98)00487-3","volume":"17","author":"TP Monath","year":"1999","unstructured":"Monath TP, Soike K, Levenbook I, et al.: Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates. Vaccine 1999, 17:1869\u20131882.","journal-title":"Vaccine"},{"key":"98_CR49","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0264-410X(01)00457-1","volume":"20","author":"TP Monath","year":"2002","unstructured":"Monath TP, McCarthy K, Bedford P, et al.: Clinical proof of principle for ChimeriVax: recombinant live, attenuated vaccines against flavivirus infections. Vaccine 2002, 20:1004\u20131018.","journal-title":"Vaccine"},{"key":"98_CR50","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1086\/378356","volume":"188","author":"TP Monath","year":"2003","unstructured":"Monath TP, Guirakhoo F, Nichols R, et al. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen. J Infect Dis 2003, 188:1213\u20131230.","journal-title":"J Infect Dis"}],"container-title":["Current Infectious Disease Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-010-0098-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11908-010-0098-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-010-0098-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T12:19:46Z","timestamp":1635250786000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11908-010-0098-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,22]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["98"],"URL":"https:\/\/doi.org\/10.1007\/s11908-010-0098-z","relation":{},"ISSN":["1523-3847","1534-3146"],"issn-type":[{"value":"1523-3847","type":"print"},{"value":"1534-3146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,22]]}}}